205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
20.16%
Some net income increase while AVGO is negative at -9.78%. John Neff would see a short-term edge over the struggling competitor.
4.09%
Some D&A expansion while AVGO is negative at -0.37%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
600.00%
Well above AVGO's 17.96% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-22.53%
Negative yoy working capital usage while AVGO is 18.76%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
100.00%
AR growth while AVGO is negative at -9.46%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
16.46%
Inventory growth well above AVGO's 26.35%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-100.00%
Both negative yoy AP, with AVGO at -354.36%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-2988.89%
Negative yoy usage while AVGO is 68.61%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
No Data
No Data available this quarter, please select a different quarter.
28.75%
Operating cash flow growth above 1.5x AVGO's 7.23%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
11.22%
Some CapEx rise while AVGO is negative at -44.00%. John Neff would see competitor possibly building capacity while we hold back expansions.
100.00%
Acquisition growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-14.43%
Negative yoy purchasing while AVGO stands at 45.71%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
13.68%
Below 50% of AVGO's 333.33%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-100.00%
Both yoy lines negative, with AVGO at -176.92%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
7.96%
Lower net investing outflow yoy vs. AVGO's 23.56%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
100.00%
Debt repayment 1.25-1.5x AVGO's 89.41%. Bruce Berkowitz would see an edge in lowering interest burdens unless competitor invests in profitable expansions.
64.29%
Issuance growth of 64.29% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
34.30%
We have some buyback growth while AVGO is negative at -107.07%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.